Hosted on MSN1mon
Merck Just Paid Investors: How Much Did They Receive?
Merck & Co. Inc. (NYSE ... and adult vaccine products under the Gardasil, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta brands. The Animal Health segment ...
Nasdaq16d
Merck Q4 Earnings & Sales Beat Estimates, Stock Down on Weak '25 View
Merck MRK reported fourth-quarter 2024 adjusted ... Estimate of $1.66 billion and our estimate of $1.71 billion. Proquad, M-M-R II and Varivax vaccines recorded combined sales of $594 million ...